Navigation

Novartis, U.S. drug regulator agree to malaria drug trial against COVID-19

Novartis, U.S. drug regulator agree to malaria drug trial against COVID-19
Swiss drugmaker Novartis gets go-ahead from U.S. regulators to conduct tests of malaria drug against COVID-19.


Share

Post A Comment:

0 comments:

Leave a comment. Thanks!